FDA approves irinotecan as first-line therapy for colorectal cancer

被引:0
|
作者
不详
机构
来源
ONCOLOGY-NEW YORK | 2000年 / 14卷 / 05期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:652 / +
页数:2
相关论文
共 50 条
  • [1] Irinotecan in the first-line treatment of colorectal cancer
    Saltz, LB
    ONCOLOGY-NEW YORK, 1998, 12 (08): : 54 - 58
  • [2] Combination with irinotecan - the reference first-line therapy for advanced colorectal cancer
    Wilke, HW
    ONKOLOGIE, 2000, 23 : 32 - 34
  • [3] Capecitabine and irinotecan as first-line treatment of advanced colorectal cancer
    Punt, Cornelis J. A.
    Koopman, Miriam
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (11) : 1907 - 1908
  • [4] Irinotecan or oxaliplatin for first-line treatment of advanced colorectal cancer?
    Punt, CJA
    ANNALS OF ONCOLOGY, 2005, 16 (06) : 845 - 846
  • [5] First-line therapy for advanced colorectal cancer
    de Gramont A.
    Tournigand C.
    Louvet C.
    Maindrault-Goebel F.
    André T.
    Current Oncology Reports, 2005, 7 (3) : 167 - 172
  • [6] New first-line therapy for colorectal cancer
    Henney, JE
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (01): : 33 - 33
  • [7] First-line chemotherapy with irinotecan plus capecitabine for advanced colorectal cancer
    Michalaki, V.
    Gennatas, C.
    Gennatas, S.
    Vasiliou, J.
    Smyrniotis, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] First-line chemotherapy with irinotecan plus capecitabine for advanced colorectal cancer
    Park, SH
    Bang, SM
    Cho, EK
    Baek, JH
    Oh, JH
    Im, SA
    Park, YS
    Shin, DB
    Lee, JH
    ONCOLOGY, 2004, 66 (05) : 353 - 357
  • [9] Capecitabine and irinotecan as first-line treatment of advanced colorectal cancer - Reply
    Fuchs, Charles S.
    Marshall, John
    Barrueco, Jose
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (11) : 1908 - 1909
  • [10] Irinotecan plus capecitabine as first-line chemotherapy in advanced colorectal cancer
    Gennatas, C.
    Michalaki, V.
    Gennatas, S.
    Papalambros, E.
    ANTICANCER RESEARCH, 2008, 28 (3B) : 1923 - 1926